These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 11891483

  • 1. Bone marrow scintigraphy with 99m Tc labelled monoclonal anti-NCA 90 Fab' fragment: a feasibility study and comparison of bone marrow uptake with 99m Tc labelled monoclonal anti-NCA 95 antigranulocyte antibody.
    Ivancevic V, Huic D, Wolter A, Munz DL.
    Nucl Med Commun; 2002 Mar; 23(3):249-55. PubMed ID: 11891483
    [Abstract] [Full Text] [Related]

  • 2. Imaging of low-grade bone infection with a technetium-99m labelled monoclonal anti-NCA-90 Fab' fragment in patients with previous joint surgery.
    Ivanćević V, Perka C, Hasart O, Sandrock D, Munz DL.
    Eur J Nucl Med Mol Imaging; 2002 Apr; 29(4):547-51. PubMed ID: 11914895
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Nonspecific bowel activity in imaging inflammation with Tc-99m labelled monoclonal anti-NCA-90 Fab' fragment MN3.
    Ivancević V, Wolter A, Munz DL.
    Nuklearmedizin; 2001 Jun; 40(3):71-4. PubMed ID: 11475075
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Photopenic lesions in bone marrow scintigraphy using technetium-99m labeled antigranulocyte antibody without known tumour.
    Krause T, Reinhardt M, Nitzsche E, Moser E.
    Nuklearmedizin; 1999 Apr; 38(3):85-9. PubMed ID: 10320994
    [Abstract] [Full Text] [Related]

  • 7. Bone marrow scintigraphy using technetium-99m-antigranulocyte antibody in hematologic disorders.
    Chung JK, Yeo J, Lee DS, Park S, Lee MC, Kim BK, Koh CS.
    J Nucl Med; 1996 Jun; 37(6):978-82. PubMed ID: 8683326
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Technetium-99m-labeled antigranulocyte antibody bone marrow scintigraphy.
    Lee KH, Chung JK, Choi CW, Jeong JM, Lee DS, Bang YJ, Lee MC, Kim NK, Koh CS.
    J Nucl Med; 1995 Oct; 36(10):1800-5. PubMed ID: 7562046
    [Abstract] [Full Text] [Related]

  • 10. Development of bone marrow immunoscintigraphy using a Tc-99m labeled anti-NCA-95 monoclonal antibody.
    Choi CW, Chung JK, Lee DS, Lee MC, Chung HK, Kim BK, Koh CS.
    Nucl Med Biol; 1995 Jan; 22(1):117-23. PubMed ID: 7735161
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Tc-99m labelled anti CD 66 antigranulocyte antibody imaging for assessment of bone marrow reserve.
    Matthies A, Reinhardt M, Palmedo H, Ezziddin S, Abramowski B, Kuhn W, Biersack HJ, von Mallek D.
    Cancer Invest; 2005 Jan; 23(2):119-22. PubMed ID: 15813503
    [Abstract] [Full Text] [Related]

  • 14. Intraindividual comparison of 99mTc-labelled anti-SSEA-1 antigranulocyte antibody and 99mTc-HMPAO labelled white blood cells for the imaging of infection.
    Gratz S, Behr T, Herrmann A, Dresing K, Tarditi L, Franceschini R, Rhodes B, Stürmer KM, Becker W.
    Eur J Nucl Med; 1998 Apr; 25(4):386-93. PubMed ID: 9553168
    [Abstract] [Full Text] [Related]

  • 15. Bone marrow immunoscintigraphy using technetium-99m anti-granulocyte antibody in multiple myeloma.
    Sohn SK, Ahn BC, Lee SW, Kim DH, Chun KA, Kim JG, Park SH, Song HS, Lee B, Lee J.
    Eur J Nucl Med Mol Imaging; 2002 May; 29(5):591-6. PubMed ID: 11976796
    [Abstract] [Full Text] [Related]

  • 16. 99mTc-antigranulocyte bone marrow scintigraphy of breast and prostate skeletal metastases.
    Limouris GS, Voliotopoulos V, Stavraka A, Vlahos L.
    Anticancer Res; 1997 May; 17(3B):1615-8. PubMed ID: 9179204
    [Abstract] [Full Text] [Related]

  • 17. Bone marrow immunoscintigraphy versus conventional bone scintigraphy in the diagnosis of skeletal metastases in urogenital malignancies.
    Zoeller G, Sandrock D, Munz DL, Ringert RH.
    Eur Urol; 1994 May; 26(2):141-4. PubMed ID: 7957469
    [Abstract] [Full Text] [Related]

  • 18. Bone marrow scintigraphy with technetium-99m anti-NCA-95 to monitor therapy in malignant osteopetrosis.
    Thelen MH, Eschmann SM, Moll-Kotowski M, Dopfer R, Bares R.
    J Nucl Med; 1998 Jun; 39(6):1033-5. PubMed ID: 9627340
    [Abstract] [Full Text] [Related]

  • 19. 99Tcm-LL1: a potential new bone marrow imaging agent.
    Juweid M, Dunn RM, Sharkey RM, Rubin AD, Hansen HJ, Goldenberg DM.
    Nucl Med Commun; 1997 Feb; 18(2):142-8. PubMed ID: 9076770
    [Abstract] [Full Text] [Related]

  • 20. Bone marrow immunoscintigraphy in haematological patients with pancytopenia: preliminary results.
    Huić D, Ivancević V, Aurer I, Dodig D, Nemet D, Labar B, Poropat M, Munz DL.
    Nucl Med Commun; 2002 Aug; 23(8):757-63. PubMed ID: 12124481
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.